Luther King Capital Management (LKCM)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.92M | Buy |
|
|||||
|
2025
Q1 | $6.83M | Sell |
|
|||||
|
2024
Q4 | $9.66M | Sell |
|
|||||
|
2024
Q3 | $12.9M | Sell |
|
|||||
|
2024
Q2 | $65.8M | Sell |
|
|||||
|
2024
Q1 | $95.2M | Sell |
|
|||||
|
2023
Q4 | $86.7M | Sell |
|
|||||
|
2023
Q3 | $75.6M | Sell |
|
|||||
|
2023
Q2 | $84.5M | Sell |
|
|||||
|
2023
Q1 | $83.3M | Sell |
|
|||||
|
2022
Q4 | $93.8M | Sell |
|
|||||
|
2022
Q3 | $94.3M | Sell |
|
|||||
|
2022
Q2 | $111M | Sell |
|
|||||
|
2022
Q1 | $161M | Buy |
|
|||||
|
2021
Q4 | $209M | Buy |
|
|||||
|
2021
Q3 | $225M | Sell |
|
|||||
|
2021
Q2 | $203M | Buy |
|
|||||
|
2021
Q1 | $153M | Buy |
|
|||||
|
2020
Q4 | $119M | Buy |
|
|||||
|
2020
Q3 | $95.7M | Buy |
|
|||||
|
2020
Q2 | $71.2M | Buy |
|
|||||
|
2020
Q1 | $50.2M | Sell |
|
|||||
|
2019
Q4 | $61.4M | Buy |
|
|||||
|
2019
Q3 | $48.5M | Buy |
|
|||||
|
2019
Q2 | $48.8M | Buy |
|
|||||
|
2019
Q1 | $17.9M | Buy |
|
|||||
|
2018
Q4 | $10.5M | Buy |
|
|||||
|
2018
Q3 | $9.59M | Sell |
|
|||||
|
2018
Q2 | $8.14M | Sell |
|
|||||
|
2018
Q1 | $8.59M | Sell |
|
|||||
|
2017
Q4 | $9.39M | Sell |
|
|||||
|
2017
Q3 | $9.81M | Sell |
|
|||||
|
2017
Q2 | $9.91M | Sell |
|
|||||
|
2017
Q1 | $10.3M | Sell |
|
|||||
|
2016
Q4 | $11.1M | Sell |
|
|||||
|
2016
Q3 | $16.9M | Sell |
|
|||||
|
2016
Q2 | $19.9M | Sell |
|
|||||
|
2016
Q1 | $20M | Sell |
|
|||||
|
2015
Q4 | $32.5M | Sell |
|
|||||
|
2015
Q3 | $29.6M | Sell |
|
|||||
|
2015
Q2 | $35.7M | Sell |
|
|||||
|
2015
Q1 | $40.8M | Buy |
|
|||||
|
2014
Q4 | $32.2M | Buy |
|
|||||
|
2014
Q3 | $22.2M | Buy |
|